Navigation Links
DATATRAK CTO Elected as CDISC Advisory Board Chair-Elect
Date:2/5/2013

CLEVELAND, Feb. 5, 2013 /PRNewswire/ -- DATATRAK International, Inc. (OTCQX: DTRK), a leader in developing cloud-based, unified eClinical® technologies and delivering related services for the clinical trials industry, today announced Chris Wilke , DATATRAK's Chief Technology Officer, was elected as the CDISC Advisory Board's (CAB) Chair-Elect. 

(Logo:  http://photos.prnewswire.com/prnh/20130107/CL38347LOGO)

"We are very pleased to have Chris Wilke as a member of the CDISC Advisory Board's leadership team. His many years of industry experience will add immense value to this group and will further promote our vision to inform patient care and safety through higher quality medical research," said Dr. Rebecca Kush , President and CEO, CDISC.

"Standards are key to effective sharing of clinical research data and ultimately, improving patient health," stated Chris Wilke , DATATRAK's CTO.  "After serving as a member of the Advisory Board for two years, I am excited to take a more active role in furthering CDISC's mission to develop and support global, platform-independent data standards."

As a Charter Platinum Member of CDISC, DATATRAK has a long history of supporting CDISC and its mission to define and implement standards industry-wide.  The Company currently holds CDISC Registered Solution Provider (RSP) status in the following categories:


  • CDASH
  • Define.XML
  • LAB
  • Operational Data Model
  • Study Data Tabulation Model

About DATATRAK

DATATRAK is the leader of unified eClinical® technologies and related services for the clinical trials industry.  Using the DATATRAK ONE™ multi-product, cloud-based clinical research platform, DATATRAK's Clinical and Consulting Services™ group assists clients in conducting Phase I-IV drug and device studies in multiple languages throughout the world. DATATRAK has offices located in Cleveland, Ohio; Bryan, Texas; and Cary (RTP), North Carolina. For more information, visit www.datatrak.net.

Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements are made based on management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements.  For a list of certain factors that may cause actual results to differ materially from those contemplated in these forward looking statements, please see the Company's report filed with the OTCQX Market on November 14, 2012 announcing its results for the three-month period ending September 30, 2012. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE DATATRAK International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. DATATRAK November Industry Events
2. DATATRAK International, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
3. DATATRAK International, Inc. to Webcast, Live, at RetailInvestorConferences.com on July 12th
4. DATATRAK Announces Accreditation Program
5. DATATRAK Expands CDISC Registered Solutions Provider Standards
6. NTT DATA Licenses DATATRAK ONE™ for China
7. Catherine M. Burzik Elected as BD Director
8. Varian Equipment Selected to Equip New Cancer Center in Algeria and Enable More Advanced Radiotherapy Treatments for Patients
9. Cerulean Pharmas Lead Candidate Selected as a "Top 10 Oncology Project to Watch"
10. Acuo Technologies Selected in Department of Defense Award to Deliver Vendor Neutral Archive for U.S. Army and U.S. Navy Medical Commands
11. Greenphires ClinCard Technology Platform selected by top 5 pharmaceutical company for long-term global clinical trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016 Dehaier Medical Systems Ltd. (NASDAQ: ... develops, markets and sells medical devices and wearable sleep ... a strategic cooperation agreement with Hongyuan Supply Chain Management ... on June 20, 2016, to develop Dehaier,s new Internet ... agreement, Dehaier will leverage Hongyuan Supply Chain,s sales platform ...
(Date:6/24/2016)... Research and Markets has announced the addition of the ... to their offering. ... World Market for Companion Diagnostics covers the world market for ... report includes the following: , World IVD ... (N. America, EU, ROW), 2015-2020 , World IVD Companion ...
(Date:6/24/2016)... LEXINGTON, Mass. , June 24, 2016   ... specialty pharmaceutical company developing innovative inhaled drugs, announced today ... when Russell Investments reconstituted its comprehensive set ... 2016. "This is an important milestone for ... "It will increase shareholder awareness of our progress in ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... The ... in Dallas that it will receive two significant new grants to support its ... PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists for ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is ... Road To Recovery® program to drive cancer patients to and from their cancer treatments. ... the highest quality of life and ongoing independence. Getting to and from medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented its ... Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor the outstanding ... Medicine Practice and Pediatric Emergency Medicine Practice. , “With this award, we ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... actively feeding the Frederick area economy by obtaining investment capital for emerging technology ... past 2½ years that have already resulted in more than a million dollars ...
(Date:6/24/2016)... MD (PRWEB) , ... June 24, 2016 , ... ... protocols for human induced pluripotent stem (iPS) cells and other difficult to transfect ... G9™ Cloning Medium. The PluriQ™ G9™ Gene Editing System is a ...
Breaking Medicine News(10 mins):